[1] Fredriksson T,Pettersson U.Severe psoriasisoral therapy with a new retinoid.Dermatologica,1978,157(4):238-244.
[2] Smith CH,Jackson K,Chinn S,et al.A double blind,randomized,controlled clinical trial to assess the efficacy of a new coal tar preparation(Exorex) in the treatment of chronic,plaque type psoriasis.Clin Exp Dermatol,2000,25(8):580-583.
[3] Garcia RL,Coltrera MD,Gown AM.Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed,embedded tissues.Comparison with flow cytometric analysis.Am J Pathol,1989,134(4):733-739.
[4] 蔡绥勍,孙国均,郑敏.银屑病患者皮损及非皮损部位粘附分子免疫组化研究.中华皮肤科杂志,1998,31(2):79-81.
[5] Dvorak AM,Feng D.The vesiculo-vacuolar organelle(VVO).A new endothelial cell permeability organelle.J Histochem Cytochem,2001,49(4):419-432.
[6] Bhushan M,McLaughlin B,Weiss JB,et al.Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.Br J Dermatol,1999,141(6):1054-1060.
[7] 陈积愫,郑敏.寻常型银屑病患者血管内皮生长因子及单核细胞趋化因子-1表达的研究.中华皮肤科杂志,2002,35(2):111-113.
[8] 蔡绥勍,郑敏,孙国均,等.银屑病患者血清和皮损中血管内皮细胞粘附分子的对比研究.中华皮肤科杂志,2002,35(2):99-101.
[9] Hasan J,Jayson GC.VEGF antagonists.Expert Opin Biol Ther,2001,1(4):703-718.
[10] Yusuf-Makagiansar H,Anderson ME,Yakovleva TV,Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases.Med Res Rev,2002,22(2):146-167. |
